Member Info for ShareSting

L2 looking strong for a push into 50’s.

3 code 1’s in the last 24hours if anyone believes.

Think we will see some news soon. Gzzz I have been rattling on about overdue TR1’s for weeks now :-)

Morning all.
So I see a few traders have jumped ship at 50p earlier. Some expecting a back test of low 40’s.
For me I think we will see 50’s by this PM.
FinCap advise £1.20 pre news, so we are still looking very cheap in the eyes of our broker.... and others !!

1.5m trades already, the buyer is still active folks !!

good volume today.
Looks well set up for tomorrow.... come on America make your move.

Sorry if my post came across as patronising.
It was genuine.

As for the price action, looks like we might get another push into close !!

Well done to everyone that top sliced to make them feel better with their investment.
Personally I am holding until much higher. I believe FinCap are still clearing, but will ease the price North.
This is Aim the most corrupt market I’ve ever experienced!

I think a TR1 update is more likely than any news in the Phase2.
Buy price now back at 45p, I hope we can hold this level today. I would imagine allot of PI’s would have taken their 30% from buying at last weeks low.

IMO this is not warmed up yet and it’s too early to think about a slice. With FinCap at £1.20 pre news and the R number increasing around the world, now is the time for SNG to start negotiating global licence deals !!

There looks to be a chunky sell order on L2 which needs to clear prior to our next move up.

FinCap has £1.20 before news so still some way to go.

I see some chatter about a US deal (which would make sense) but 100% unverified at this stage.

IMO we have a long way to go yet.

Simm, tell theM £5 per share minimum;-)

That’s old thinking. We can all change our minds.
I doubt we would want them as partners after the asthma issues.

I think after 15 years of development, three phase2 publications due this summer and wave2 C-19 issues hitting, personally I would be quite comfortable with Synairgen’s drug aspirations.

Astra Zeneca’s product don’t bother me one ounce. Hence why I am invested here and not there.

Any my view only.

Evening all

I’m trying to post less now and to be honest there are a number of cracking people on here now with better knowledge.

For what it’s worth my take on a few things.

1. From Richard, it’s clear there is allot of valuable data (more than most) from the COPD test. The test results also cross a number of viral infections, including Covid strains.
So the independent company had allot of data to crunch and cross reference. Synairgen experts (the best in the world) will also want to analyse and potentially challenge conclusions reached by the independent co. All this takes time. We don’t want this rushed as they are looking to use the COPD data, Asthma data and C-19 data as part of their emergency drug application.

2. Timing. I thing we could see data released together, so the publication will separate COPD and Hospital and then bring the two together with all other data sets, which justifies their application to MHRA and FDA.

3. I believe this will deliver the offer we are all looking for.

4. Home trials needs PR. I have tweeted MP’s contacted news channels this weekend. We should also place a link to the Synairgen Home trial website on our Facebook and LinkedIn.

5. I have concerns over Acacia selling out. I truly hope they clear prior to news. We don’t want the share price being held back any longer. The last 4 months have been tough with constant selling into any gains. We deserve a free run North !!

6. The is Aim so expect the unexpected!

Let’s hope we can land 60’s before the news !

GLA

Two things :

1. The COPD trials results are data Rich. So will support FDA and MHRA applications.

2. The company strategy just 6 months ago was a buyout or licence deal. I believe this has not changed.

DYOR.

If I was the CEO I would be arranging for the major drug and pharmaceutical companies they were talking with last year to visit with their cheque books in hand ;-)

**********************O5MPiE0BZPhTpSiW7ueemg
Lima

Everyone should be allowed to voice their thoughts.
It’s just a shame the board gets full of spam.

If we can all spend 5 minutes emailing our MP asking why UK Gov is not supporting our trial, that would add value and also might just help the at risk !

Lima yes I think if we all spend a 1hr in a targeted approach it would add more value.
The issue with this board is it gets lost in the noise.
Are you a member of the Telegram group (app). That way we can coordinate off line and then post on here ?

I wrote to my MP
I explained that SNG001 is a drug being made available to the AT-Risk and it would support our local constituents.
I voiced my frustration that it was not receiving the level of support from Ministers in terms of helping increase awareness. I suggested that this was potentially putting more people at risk and also delaying the potentially life saving results. I noted the trials were fully supported by the NIHR so there was no reason why Matt Han**** couldn’t promote the trials like he has with other drugs.

The PR team have confirmed :

They are happy for investors to reach out to their local MP’s to lobby for increased awareness of the trial.
They said it appears the Government are solely focused on potential vaccines and treatments in the Accord programme.
They also confirmed that news is reaching the US.

So as discussed last night it appear Matt Han**** is only interested in talking about his Oxford mates and is refusing to support / increase awareness for our trial. He is putting the at-risk at higher risk by ignoring the trial. Disgusting !

As Acacia and Lansdowne continue to sell the frustration for loyal shareholders continues.
Time to switch off for the day.